nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolmetin—osteoarthritis—Prednisone—multiple sclerosis	0.326	0.5	CpDpCtD
Tolmetin—osteoarthritis—Methylprednisolone—multiple sclerosis	0.326	0.5	CpDpCtD
Tolmetin—PTGS2—Triamcinolone—multiple sclerosis	0.0695	0.377	CbGbCtD
Tolmetin—PTGS2—Betamethasone—multiple sclerosis	0.0596	0.323	CbGbCtD
Tolmetin—PTGS2—Dexamethasone—multiple sclerosis	0.0347	0.188	CbGbCtD
Tolmetin—SLC22A6—Methotrexate—multiple sclerosis	0.0206	0.112	CbGbCtD
Tolmetin—PTGS2—leg—multiple sclerosis	0.00137	0.117	CbGeAlD
Tolmetin—TDO2—nervous system—multiple sclerosis	0.00115	0.0982	CbGeAlD
Tolmetin—TDO2—central nervous system—multiple sclerosis	0.0011	0.0945	CbGeAlD
Tolmetin—Weight decreased—Fingolimod—multiple sclerosis	0.00101	0.0195	CcSEcCtD
Tolmetin—TDO2—brain—multiple sclerosis	0.000877	0.075	CbGeAlD
Tolmetin—CXCL8—medulla oblongata—multiple sclerosis	0.00084	0.0719	CbGeAlD
Tolmetin—Vascular purpura—Cladribine—multiple sclerosis	0.000821	0.0158	CcSEcCtD
Tolmetin—Haemolytic anaemia—Cladribine—multiple sclerosis	0.000814	0.0156	CcSEcCtD
Tolmetin—CXCL8—midbrain—multiple sclerosis	0.000768	0.0658	CbGeAlD
Tolmetin—Purpura—Cladribine—multiple sclerosis	0.000762	0.0146	CcSEcCtD
Tolmetin—Proteinuria—Mitoxantrone—multiple sclerosis	0.000757	0.0145	CcSEcCtD
Tolmetin—CXCL8—spinal cord—multiple sclerosis	0.000749	0.0642	CbGeAlD
Tolmetin—Protein urine present—Mitoxantrone—multiple sclerosis	0.000747	0.0143	CcSEcCtD
Tolmetin—Toxic epidermal necrolysis—Cladribine—multiple sclerosis	0.000661	0.0127	CcSEcCtD
Tolmetin—Blood urea increased—Mitoxantrone—multiple sclerosis	0.000628	0.0121	CcSEcCtD
Tolmetin—Abdominal discomfort—Cladribine—multiple sclerosis	0.000609	0.0117	CcSEcCtD
Tolmetin—CXCL8—cerebellum—multiple sclerosis	0.000594	0.0509	CbGeAlD
Tolmetin—Renal failure—Cladribine—multiple sclerosis	0.000556	0.0107	CcSEcCtD
Tolmetin—Urinary tract infection—Cladribine—multiple sclerosis	0.00055	0.0106	CcSEcCtD
Tolmetin—Toxic epidermal necrolysis—Azathioprine—multiple sclerosis	0.000538	0.0103	CcSEcCtD
Tolmetin—PTGS2—Fluocinonide—Methylprednisolone—multiple sclerosis	0.000535	0.159	CbGdCrCtD
Tolmetin—Epistaxis—Cladribine—multiple sclerosis	0.000534	0.0103	CcSEcCtD
Tolmetin—Cardiac failure congestive—Mitoxantrone—multiple sclerosis	0.000532	0.0102	CcSEcCtD
Tolmetin—PTGS2—Fluocinonide—Betamethasone—multiple sclerosis	0.000526	0.156	CbGdCrCtD
Tolmetin—PTGS2—Fluocinonide—Dexamethasone—multiple sclerosis	0.000526	0.156	CbGdCrCtD
Tolmetin—PTGS2—Fluocinonide—Triamcinolone—multiple sclerosis	0.000514	0.153	CbGdCrCtD
Tolmetin—Anaphylactoid reaction—Mitoxantrone—multiple sclerosis	0.000499	0.00959	CcSEcCtD
Tolmetin—Abdominal discomfort—Azathioprine—multiple sclerosis	0.000495	0.00951	CcSEcCtD
Tolmetin—Gastrointestinal haemorrhage—Mitoxantrone—multiple sclerosis	0.000483	0.00928	CcSEcCtD
Tolmetin—CXCL8—brain—multiple sclerosis	0.000483	0.0413	CbGeAlD
Tolmetin—Erythema multiforme—Cladribine—multiple sclerosis	0.00048	0.00923	CcSEcCtD
Tolmetin—Asthenia—Fingolimod—multiple sclerosis	0.000457	0.00878	CcSEcCtD
Tolmetin—MPO—spinal cord—multiple sclerosis	0.000438	0.0375	CbGeAlD
Tolmetin—Cardiac failure congestive—Prednisolone—multiple sclerosis	0.000437	0.00839	CcSEcCtD
Tolmetin—Flatulence—Cladribine—multiple sclerosis	0.000436	0.00838	CcSEcCtD
Tolmetin—Diarrhoea—Fingolimod—multiple sclerosis	0.000436	0.00838	CcSEcCtD
Tolmetin—Agranulocytosis—Azathioprine—multiple sclerosis	0.00043	0.00826	CcSEcCtD
Tolmetin—Dizziness—Fingolimod—multiple sclerosis	0.000421	0.00809	CcSEcCtD
Tolmetin—Visual disturbance—Prednisolone—multiple sclerosis	0.000418	0.00803	CcSEcCtD
Tolmetin—Anaphylactoid reaction—Prednisolone—multiple sclerosis	0.000409	0.00787	CcSEcCtD
Tolmetin—Vascular purpura—Triamcinolone—multiple sclerosis	0.000407	0.00783	CcSEcCtD
Tolmetin—Cardiac failure congestive—Triamcinolone—multiple sclerosis	0.000402	0.00772	CcSEcCtD
Tolmetin—Cardiac failure congestive—Methylprednisolone—multiple sclerosis	0.000401	0.0077	CcSEcCtD
Tolmetin—Headache—Fingolimod—multiple sclerosis	0.000399	0.00767	CcSEcCtD
Tolmetin—Erythema multiforme—Azathioprine—multiple sclerosis	0.000391	0.00751	CcSEcCtD
Tolmetin—Weight increased—Mitoxantrone—multiple sclerosis	0.00038	0.0073	CcSEcCtD
Tolmetin—Purpura—Triamcinolone—multiple sclerosis	0.000378	0.00726	CcSEcCtD
Tolmetin—Weight decreased—Mitoxantrone—multiple sclerosis	0.000378	0.00726	CcSEcCtD
Tolmetin—Proteinuria—Methotrexate—multiple sclerosis	0.000377	0.00725	CcSEcCtD
Tolmetin—SLC22A6—brain—multiple sclerosis	0.000377	0.0323	CbGeAlD
Tolmetin—Chest pain—Cladribine—multiple sclerosis	0.000377	0.00724	CcSEcCtD
Tolmetin—Anaphylactoid reaction—Triamcinolone—multiple sclerosis	0.000376	0.00723	CcSEcCtD
Tolmetin—Anaphylactoid reaction—Methylprednisolone—multiple sclerosis	0.000376	0.00722	CcSEcCtD
Tolmetin—Drowsiness—Mitoxantrone—multiple sclerosis	0.000372	0.00715	CcSEcCtD
Tolmetin—Protein urine present—Methotrexate—multiple sclerosis	0.000372	0.00715	CcSEcCtD
Tolmetin—MPO—nervous system—multiple sclerosis	0.000369	0.0316	CbGeAlD
Tolmetin—Renal failure—Mitoxantrone—multiple sclerosis	0.000366	0.00703	CcSEcCtD
Tolmetin—Cardiac failure congestive—Betamethasone—multiple sclerosis	0.000364	0.007	CcSEcCtD
Tolmetin—Cardiac failure congestive—Dexamethasone—multiple sclerosis	0.000364	0.007	CcSEcCtD
Tolmetin—Stomatitis—Mitoxantrone—multiple sclerosis	0.000363	0.00697	CcSEcCtD
Tolmetin—Urinary tract infection—Mitoxantrone—multiple sclerosis	0.000362	0.00695	CcSEcCtD
Tolmetin—Oedema—Cladribine—multiple sclerosis	0.000361	0.00694	CcSEcCtD
Tolmetin—Glossitis—Methotrexate—multiple sclerosis	0.00036	0.00691	CcSEcCtD
Tolmetin—MPO—central nervous system—multiple sclerosis	0.000356	0.0304	CbGeAlD
Tolmetin—Haematuria—Mitoxantrone—multiple sclerosis	0.000355	0.00682	CcSEcCtD
Tolmetin—Thrombocytopenia—Cladribine—multiple sclerosis	0.000353	0.00679	CcSEcCtD
Tolmetin—Visual disturbance—Betamethasone—multiple sclerosis	0.000349	0.0067	CcSEcCtD
Tolmetin—Visual disturbance—Dexamethasone—multiple sclerosis	0.000349	0.0067	CcSEcCtD
Tolmetin—Agranulocytosis—Mitoxantrone—multiple sclerosis	0.000347	0.00667	CcSEcCtD
Tolmetin—Anaphylactoid reaction—Dexamethasone—multiple sclerosis	0.000342	0.00656	CcSEcCtD
Tolmetin—Anaphylactoid reaction—Betamethasone—multiple sclerosis	0.000342	0.00656	CcSEcCtD
Tolmetin—Hepatitis—Mitoxantrone—multiple sclerosis	0.000334	0.00642	CcSEcCtD
Tolmetin—PTGS2—Fluticasone Propionate—Methylprednisolone—multiple sclerosis	0.000323	0.0957	CbGdCrCtD
Tolmetin—Vascular purpura—Prednisone—multiple sclerosis	0.000322	0.00618	CcSEcCtD
Tolmetin—Somnolence—Cladribine—multiple sclerosis	0.000321	0.00617	CcSEcCtD
Tolmetin—PTGS2—Fluticasone Propionate—Betamethasone—multiple sclerosis	0.000317	0.0942	CbGdCrCtD
Tolmetin—PTGS2—Fluticasone Propionate—Dexamethasone—multiple sclerosis	0.000317	0.0942	CbGdCrCtD
Tolmetin—Cardiac failure congestive—Prednisone—multiple sclerosis	0.000317	0.0061	CcSEcCtD
Tolmetin—Weight increased—Prednisolone—multiple sclerosis	0.000312	0.00599	CcSEcCtD
Tolmetin—PTGS2—Fluticasone Propionate—Triamcinolone—multiple sclerosis	0.00031	0.0921	CbGdCrCtD
Tolmetin—Constipation—Cladribine—multiple sclerosis	0.000309	0.00593	CcSEcCtD
Tolmetin—Purpura—Prednisone—multiple sclerosis	0.000299	0.00574	CcSEcCtD
Tolmetin—Gastrointestinal pain—Cladribine—multiple sclerosis	0.000295	0.00567	CcSEcCtD
Tolmetin—Gastrointestinal haemorrhage—Prednisone—multiple sclerosis	0.000288	0.00553	CcSEcCtD
Tolmetin—Thrombocytopenia—Azathioprine—multiple sclerosis	0.000287	0.00552	CcSEcCtD
Tolmetin—Urticaria—Cladribine—multiple sclerosis	0.000287	0.00551	CcSEcCtD
Tolmetin—Weight increased—Triamcinolone—multiple sclerosis	0.000287	0.00551	CcSEcCtD
Tolmetin—Weight increased—Methylprednisolone—multiple sclerosis	0.000286	0.00549	CcSEcCtD
Tolmetin—Body temperature increased—Cladribine—multiple sclerosis	0.000285	0.00549	CcSEcCtD
Tolmetin—Abdominal pain—Cladribine—multiple sclerosis	0.000285	0.00549	CcSEcCtD
Tolmetin—MPO—brain—multiple sclerosis	0.000282	0.0242	CbGeAlD
Tolmetin—Lymphadenopathy—Methotrexate—multiple sclerosis	0.000282	0.00542	CcSEcCtD
Tolmetin—Epistaxis—Triamcinolone—multiple sclerosis	0.000265	0.00509	CcSEcCtD
Tolmetin—Visual impairment—Prednisolone—multiple sclerosis	0.000264	0.00508	CcSEcCtD
Tolmetin—Weight increased—Dexamethasone—multiple sclerosis	0.00026	0.005	CcSEcCtD
Tolmetin—Weight increased—Betamethasone—multiple sclerosis	0.00026	0.005	CcSEcCtD
Tolmetin—Asthenia—Cladribine—multiple sclerosis	0.000259	0.00498	CcSEcCtD
Tolmetin—Weight decreased—Betamethasone—multiple sclerosis	0.000258	0.00497	CcSEcCtD
Tolmetin—Weight decreased—Dexamethasone—multiple sclerosis	0.000258	0.00497	CcSEcCtD
Tolmetin—Visual disturbance—Methotrexate—multiple sclerosis	0.000254	0.00488	CcSEcCtD
Tolmetin—Anaphylactoid reaction—Methotrexate—multiple sclerosis	0.000249	0.00478	CcSEcCtD
Tolmetin—Chest pain—Mitoxantrone—multiple sclerosis	0.000248	0.00476	CcSEcCtD
Tolmetin—Diarrhoea—Cladribine—multiple sclerosis	0.000247	0.00475	CcSEcCtD
Tolmetin—Visual impairment—Methylprednisolone—multiple sclerosis	0.000242	0.00466	CcSEcCtD
Tolmetin—Gastrointestinal pain—Azathioprine—multiple sclerosis	0.00024	0.00461	CcSEcCtD
Tolmetin—Dizziness—Cladribine—multiple sclerosis	0.000239	0.00459	CcSEcCtD
Tolmetin—Oedema—Mitoxantrone—multiple sclerosis	0.000237	0.00456	CcSEcCtD
Tolmetin—Anaphylactic shock—Mitoxantrone—multiple sclerosis	0.000237	0.00456	CcSEcCtD
Tolmetin—Thrombocytopenia—Mitoxantrone—multiple sclerosis	0.000232	0.00447	CcSEcCtD
Tolmetin—Body temperature increased—Azathioprine—multiple sclerosis	0.000232	0.00446	CcSEcCtD
Tolmetin—Abdominal pain—Azathioprine—multiple sclerosis	0.000232	0.00446	CcSEcCtD
Tolmetin—Vomiting—Cladribine—multiple sclerosis	0.00023	0.00441	CcSEcCtD
Tolmetin—Weight increased—Prednisone—multiple sclerosis	0.000226	0.00435	CcSEcCtD
Tolmetin—Headache—Cladribine—multiple sclerosis	0.000226	0.00435	CcSEcCtD
Tolmetin—Weight decreased—Prednisone—multiple sclerosis	0.000225	0.00433	CcSEcCtD
Tolmetin—PTGS2—medulla oblongata—multiple sclerosis	0.000223	0.0191	CbGeAlD
Tolmetin—Visual impairment—Dexamethasone—multiple sclerosis	0.00022	0.00424	CcSEcCtD
Tolmetin—Visual impairment—Betamethasone—multiple sclerosis	0.00022	0.00424	CcSEcCtD
Tolmetin—Toxic epidermal necrolysis—Methotrexate—multiple sclerosis	0.000217	0.00416	CcSEcCtD
Tolmetin—Nausea—Cladribine—multiple sclerosis	0.000214	0.00412	CcSEcCtD
Tolmetin—Somnolence—Mitoxantrone—multiple sclerosis	0.000211	0.00405	CcSEcCtD
Tolmetin—Dyspepsia—Mitoxantrone—multiple sclerosis	0.000209	0.00401	CcSEcCtD
Tolmetin—PTGS1—spinal cord—multiple sclerosis	0.000208	0.0178	CbGeAlD
Tolmetin—PTGS2—midbrain—multiple sclerosis	0.000204	0.0174	CbGeAlD
Tolmetin—Constipation—Mitoxantrone—multiple sclerosis	0.000203	0.0039	CcSEcCtD
Tolmetin—Diarrhoea—Azathioprine—multiple sclerosis	0.000201	0.00386	CcSEcCtD
Tolmetin—Abdominal discomfort—Methotrexate—multiple sclerosis	0.000199	0.00383	CcSEcCtD
Tolmetin—PTGS2—spinal cord—multiple sclerosis	0.000199	0.017	CbGeAlD
Tolmetin—Anaphylactic shock—Prednisolone—multiple sclerosis	0.000195	0.00374	CcSEcCtD
Tolmetin—Oedema—Prednisolone—multiple sclerosis	0.000195	0.00374	CcSEcCtD
Tolmetin—Dysuria—Methotrexate—multiple sclerosis	0.000194	0.00374	CcSEcCtD
Tolmetin—Dizziness—Azathioprine—multiple sclerosis	0.000194	0.00373	CcSEcCtD
Tolmetin—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.000194	0.00373	CcSEcCtD
Tolmetin—Urticaria—Mitoxantrone—multiple sclerosis	0.000189	0.00362	CcSEcCtD
Tolmetin—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000188	0.00361	CcSEcCtD
Tolmetin—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000188	0.00361	CcSEcCtD
Tolmetin—Vomiting—Azathioprine—multiple sclerosis	0.000187	0.00359	CcSEcCtD
Tolmetin—Drowsiness—Methotrexate—multiple sclerosis	0.000185	0.00356	CcSEcCtD
Tolmetin—Headache—Azathioprine—multiple sclerosis	0.000184	0.00353	CcSEcCtD
Tolmetin—Renal failure—Methotrexate—multiple sclerosis	0.000182	0.0035	CcSEcCtD
Tolmetin—Stomatitis—Methotrexate—multiple sclerosis	0.000181	0.00347	CcSEcCtD
Tolmetin—Oedema—Triamcinolone—multiple sclerosis	0.000179	0.00344	CcSEcCtD
Tolmetin—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000179	0.00344	CcSEcCtD
Tolmetin—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000179	0.00343	CcSEcCtD
Tolmetin—Haematuria—Methotrexate—multiple sclerosis	0.000177	0.0034	CcSEcCtD
Tolmetin—PTGS1—nervous system—multiple sclerosis	0.000175	0.015	CbGeAlD
Tolmetin—Epistaxis—Methotrexate—multiple sclerosis	0.000175	0.00336	CcSEcCtD
Tolmetin—Nausea—Azathioprine—multiple sclerosis	0.000174	0.00335	CcSEcCtD
Tolmetin—Agranulocytosis—Methotrexate—multiple sclerosis	0.000173	0.00332	CcSEcCtD
Tolmetin—Asthenia—Mitoxantrone—multiple sclerosis	0.00017	0.00327	CcSEcCtD
Tolmetin—PTGS1—central nervous system—multiple sclerosis	0.000169	0.0144	CbGeAlD
Tolmetin—PTGS2—nervous system—multiple sclerosis	0.000167	0.0143	CbGeAlD
Tolmetin—Hepatitis—Methotrexate—multiple sclerosis	0.000166	0.0032	CcSEcCtD
Tolmetin—Oedema—Betamethasone—multiple sclerosis	0.000162	0.00312	CcSEcCtD
Tolmetin—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000162	0.00312	CcSEcCtD
Tolmetin—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000162	0.00312	CcSEcCtD
Tolmetin—Oedema—Dexamethasone—multiple sclerosis	0.000162	0.00312	CcSEcCtD
Tolmetin—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000162	0.00312	CcSEcCtD
Tolmetin—PTGS2—central nervous system—multiple sclerosis	0.000161	0.0138	CbGeAlD
Tolmetin—Visual impairment—Methotrexate—multiple sclerosis	0.00016	0.00308	CcSEcCtD
Tolmetin—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000159	0.00306	CcSEcCtD
Tolmetin—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000159	0.00306	CcSEcCtD
Tolmetin—Dyspepsia—Triamcinolone—multiple sclerosis	0.000158	0.00303	CcSEcCtD
Tolmetin—PTGS2—cerebellum—multiple sclerosis	0.000158	0.0135	CbGeAlD
Tolmetin—Erythema multiforme—Methotrexate—multiple sclerosis	0.000157	0.00302	CcSEcCtD
Tolmetin—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000157	0.00302	CcSEcCtD
Tolmetin—Tinnitus—Methotrexate—multiple sclerosis	0.000155	0.00298	CcSEcCtD
Tolmetin—Urticaria—Prednisolone—multiple sclerosis	0.000155	0.00297	CcSEcCtD
Tolmetin—Vomiting—Mitoxantrone—multiple sclerosis	0.000151	0.0029	CcSEcCtD
Tolmetin—Headache—Mitoxantrone—multiple sclerosis	0.000149	0.00286	CcSEcCtD
Tolmetin—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000146	0.00281	CcSEcCtD
Tolmetin—Dyspepsia—Dexamethasone—multiple sclerosis	0.000143	0.00275	CcSEcCtD
Tolmetin—Dyspepsia—Betamethasone—multiple sclerosis	0.000143	0.00275	CcSEcCtD
Tolmetin—Urticaria—Triamcinolone—multiple sclerosis	0.000142	0.00273	CcSEcCtD
Tolmetin—Urticaria—Methylprednisolone—multiple sclerosis	0.000142	0.00273	CcSEcCtD
Tolmetin—Body temperature increased—Triamcinolone—multiple sclerosis	0.000142	0.00272	CcSEcCtD
Tolmetin—Anaphylactic shock—Prednisone—multiple sclerosis	0.000141	0.00272	CcSEcCtD
Tolmetin—Oedema—Prednisone—multiple sclerosis	0.000141	0.00272	CcSEcCtD
Tolmetin—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000141	0.00271	CcSEcCtD
Tolmetin—Nausea—Mitoxantrone—multiple sclerosis	0.000141	0.00271	CcSEcCtD
Tolmetin—PTGS1—brain—multiple sclerosis	0.000134	0.0115	CbGeAlD
Tolmetin—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000133	0.00255	CcSEcCtD
Tolmetin—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000133	0.00255	CcSEcCtD
Tolmetin—Urticaria—Betamethasone—multiple sclerosis	0.000129	0.00248	CcSEcCtD
Tolmetin—Urticaria—Dexamethasone—multiple sclerosis	0.000129	0.00248	CcSEcCtD
Tolmetin—SLC22A6—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	0.000129	0.00132	CbGpPWpGaD
Tolmetin—Dizziness—Prednisolone—multiple sclerosis	0.000129	0.00247	CcSEcCtD
Tolmetin—Asthenia—Triamcinolone—multiple sclerosis	0.000128	0.00247	CcSEcCtD
Tolmetin—Abdominal pain—Dexamethasone—multiple sclerosis	0.000128	0.00247	CcSEcCtD
Tolmetin—Abdominal pain—Betamethasone—multiple sclerosis	0.000128	0.00247	CcSEcCtD
Tolmetin—Body temperature increased—Dexamethasone—multiple sclerosis	0.000128	0.00247	CcSEcCtD
Tolmetin—Body temperature increased—Betamethasone—multiple sclerosis	0.000128	0.00247	CcSEcCtD
Tolmetin—CXCL8—Senescence and Autophagy in Cancer—IFNG—multiple sclerosis	0.000128	0.00132	CbGpPWpGaD
Tolmetin—Asthenia—Methylprednisolone—multiple sclerosis	0.000128	0.00246	CcSEcCtD
Tolmetin—PTGS2—brain—multiple sclerosis	0.000128	0.011	CbGeAlD
Tolmetin—CXCL8—Class A/1 (Rhodopsin-like receptors)—CCR2—multiple sclerosis	0.000128	0.00131	CbGpPWpGaD
Tolmetin—CXCL8—TSLP Signaling Pathway—IL6—multiple sclerosis	0.000127	0.00131	CbGpPWpGaD
Tolmetin—CXCL8—Corticotropin-releasing hormone—IL2—multiple sclerosis	0.000127	0.0013	CbGpPWpGaD
Tolmetin—CXCL8—Metabolism of proteins—SLC30A7—multiple sclerosis	0.000125	0.00128	CbGpPWpGaD
Tolmetin—Dyspepsia—Prednisone—multiple sclerosis	0.000125	0.00239	CcSEcCtD
Tolmetin—SLC22A6—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000124	0.00127	CbGpPWpGaD
Tolmetin—Chest pain—Methotrexate—multiple sclerosis	0.000123	0.00237	CcSEcCtD
Tolmetin—CXCL8—AP-1 transcription factor network—MYC—multiple sclerosis	0.000123	0.00127	CbGpPWpGaD
Tolmetin—CXCL8—AP-1 transcription factor network—TGFB1—multiple sclerosis	0.000123	0.00126	CbGpPWpGaD
Tolmetin—CXCL8—Peptide ligand-binding receptors—CCR5—multiple sclerosis	0.000123	0.00126	CbGpPWpGaD
Tolmetin—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000122	0.00235	CcSEcCtD
Tolmetin—PTGS2—Spinal Cord Injury—CCR2—multiple sclerosis	0.000122	0.00125	CbGpPWpGaD
Tolmetin—Headache—Prednisolone—multiple sclerosis	0.000122	0.00234	CcSEcCtD
Tolmetin—Constipation—Prednisone—multiple sclerosis	0.000121	0.00233	CcSEcCtD
Tolmetin—Dizziness—Triamcinolone—multiple sclerosis	0.000118	0.00228	CcSEcCtD
Tolmetin—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000118	0.00227	CcSEcCtD
Tolmetin—Dizziness—Methylprednisolone—multiple sclerosis	0.000118	0.00227	CcSEcCtD
Tolmetin—CXCL8—Class A/1 (Rhodopsin-like receptors)—CNR1—multiple sclerosis	0.000118	0.00121	CbGpPWpGaD
Tolmetin—CXCL8—Toll-like Receptor Signaling Pathway—IL1B—multiple sclerosis	0.000117	0.0012	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—IFNG—multiple sclerosis	0.000117	0.0012	CbGpPWpGaD
Tolmetin—Asthenia—Betamethasone—multiple sclerosis	0.000117	0.00224	CcSEcCtD
Tolmetin—Asthenia—Dexamethasone—multiple sclerosis	0.000117	0.00224	CcSEcCtD
Tolmetin—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000116	0.00222	CcSEcCtD
Tolmetin—CXCL8—GPCR downstream signaling—S1PR1—multiple sclerosis	0.000116	0.00119	CbGpPWpGaD
Tolmetin—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000116	0.00222	CcSEcCtD
Tolmetin—Nausea—Prednisolone—multiple sclerosis	0.000116	0.00222	CcSEcCtD
Tolmetin—PTGS2—Overview of nanoparticle effects—IL6—multiple sclerosis	0.000115	0.00118	CbGpPWpGaD
Tolmetin—CXCL8—G alpha (i) signalling events—CCL5—multiple sclerosis	0.000115	0.00118	CbGpPWpGaD
Tolmetin—CXCL8—Senescence and Autophagy in Cancer—IL1B—multiple sclerosis	0.000114	0.00117	CbGpPWpGaD
Tolmetin—Vomiting—Triamcinolone—multiple sclerosis	0.000114	0.00219	CcSEcCtD
Tolmetin—Vomiting—Methylprednisolone—multiple sclerosis	0.000114	0.00218	CcSEcCtD
Tolmetin—Urticaria—Prednisone—multiple sclerosis	0.000112	0.00216	CcSEcCtD
Tolmetin—Headache—Triamcinolone—multiple sclerosis	0.000112	0.00216	CcSEcCtD
Tolmetin—Headache—Methylprednisolone—multiple sclerosis	0.000112	0.00215	CcSEcCtD
Tolmetin—Body temperature increased—Prednisone—multiple sclerosis	0.000112	0.00215	CcSEcCtD
Tolmetin—Abdominal pain—Prednisone—multiple sclerosis	0.000112	0.00215	CcSEcCtD
Tolmetin—CXCL8—Allograft Rejection—TGFB1—multiple sclerosis	0.000112	0.00115	CbGpPWpGaD
Tolmetin—Diarrhoea—Betamethasone—multiple sclerosis	0.000111	0.00214	CcSEcCtD
Tolmetin—Diarrhoea—Dexamethasone—multiple sclerosis	0.000111	0.00214	CcSEcCtD
Tolmetin—CXCL8—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—multiple sclerosis	0.000111	0.00114	CbGpPWpGaD
Tolmetin—PTGS1—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000108	0.00111	CbGpPWpGaD
Tolmetin—CXCL8—GPCR ligand binding—CCL3—multiple sclerosis	0.000108	0.0011	CbGpPWpGaD
Tolmetin—Dizziness—Dexamethasone—multiple sclerosis	0.000107	0.00206	CcSEcCtD
Tolmetin—Dizziness—Betamethasone—multiple sclerosis	0.000107	0.00206	CcSEcCtD
Tolmetin—PTGS1—Selenium Micronutrient Network—ICAM1—multiple sclerosis	0.000107	0.0011	CbGpPWpGaD
Tolmetin—Nausea—Triamcinolone—multiple sclerosis	0.000106	0.00204	CcSEcCtD
Tolmetin—CXCL8—Glucocorticoid receptor regulatory network—MAPK1—multiple sclerosis	0.000106	0.00109	CbGpPWpGaD
Tolmetin—CXCL8—ATF-2 transcription factor network—IL6—multiple sclerosis	0.000106	0.00109	CbGpPWpGaD
Tolmetin—CXCL8—Class A/1 (Rhodopsin-like receptors)—CXCL10—multiple sclerosis	0.000106	0.00109	CbGpPWpGaD
Tolmetin—Nausea—Methylprednisolone—multiple sclerosis	0.000106	0.00204	CcSEcCtD
Tolmetin—Somnolence—Methotrexate—multiple sclerosis	0.000105	0.00202	CcSEcCtD
Tolmetin—CXCL8—Signaling by GPCR—S1PR1—multiple sclerosis	0.000105	0.00108	CbGpPWpGaD
Tolmetin—CXCL8—Allograft Rejection—TNF—multiple sclerosis	0.000104	0.00107	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—IL1B—multiple sclerosis	0.000104	0.00107	CbGpPWpGaD
Tolmetin—Dyspepsia—Methotrexate—multiple sclerosis	0.000104	0.002	CcSEcCtD
Tolmetin—MPO—Selenium Micronutrient Network—IL6—multiple sclerosis	0.000104	0.00107	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—IL2—multiple sclerosis	0.000104	0.00107	CbGpPWpGaD
Tolmetin—CXCL8—GPCR ligand binding—PTGER4—multiple sclerosis	0.000104	0.00106	CbGpPWpGaD
Tolmetin—CXCL8—G alpha (i) signalling events—CCR5—multiple sclerosis	0.000104	0.00106	CbGpPWpGaD
Tolmetin—Vomiting—Betamethasone—multiple sclerosis	0.000103	0.00199	CcSEcCtD
Tolmetin—Vomiting—Dexamethasone—multiple sclerosis	0.000103	0.00199	CcSEcCtD
Tolmetin—Headache—Dexamethasone—multiple sclerosis	0.000102	0.00196	CcSEcCtD
Tolmetin—Headache—Betamethasone—multiple sclerosis	0.000102	0.00196	CcSEcCtD
Tolmetin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—multiple sclerosis	0.000102	0.00104	CbGpPWpGaD
Tolmetin—Asthenia—Prednisone—multiple sclerosis	0.000102	0.00195	CcSEcCtD
Tolmetin—PTGS2—Spinal Cord Injury—CXCL10—multiple sclerosis	0.000101	0.00104	CbGpPWpGaD
Tolmetin—CXCL8—Metabolism of proteins—PABPC1—multiple sclerosis	0.000101	0.00104	CbGpPWpGaD
Tolmetin—CXCL8—GPCR ligand binding—CXCR3—multiple sclerosis	0.0001	0.00103	CbGpPWpGaD
Tolmetin—CXCL8—Corticotropin-releasing hormone—TGFB1—multiple sclerosis	9.88e-05	0.00101	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—RGS1—multiple sclerosis	9.84e-05	0.00101	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—MMP9—multiple sclerosis	9.82e-05	0.00101	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	9.78e-05	0.001	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	9.78e-05	0.001	CbGpPWpGaD
Tolmetin—CXCL8—GPCR ligand binding—CCR2—multiple sclerosis	9.73e-05	0.000999	CbGpPWpGaD
Tolmetin—CXCL8—Corticotropin-releasing hormone—MAPK1—multiple sclerosis	9.69e-05	0.000995	CbGpPWpGaD
Tolmetin—Diarrhoea—Prednisone—multiple sclerosis	9.68e-05	0.00186	CcSEcCtD
Tolmetin—Gastrointestinal pain—Methotrexate—multiple sclerosis	9.67e-05	0.00186	CcSEcCtD
Tolmetin—Nausea—Dexamethasone—multiple sclerosis	9.65e-05	0.00185	CcSEcCtD
Tolmetin—Nausea—Betamethasone—multiple sclerosis	9.65e-05	0.00185	CcSEcCtD
Tolmetin—CXCL8—Peptide ligand-binding receptors—POMC—multiple sclerosis	9.59e-05	0.000985	CbGpPWpGaD
Tolmetin—CXCL8—Senescence-Associated Secretory Phenotype (SASP)—STAT3—multiple sclerosis	9.59e-05	0.000985	CbGpPWpGaD
Tolmetin—PTGS1—Selenium Micronutrient Network—CCL2—multiple sclerosis	9.58e-05	0.000985	CbGpPWpGaD
Tolmetin—Urticaria—Methotrexate—multiple sclerosis	9.39e-05	0.00181	CcSEcCtD
Tolmetin—CXCL8—Peptide ligand-binding receptors—CCL2—multiple sclerosis	9.38e-05	0.000964	CbGpPWpGaD
Tolmetin—SLC22A6—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	9.37e-05	0.000962	CbGpPWpGaD
Tolmetin—Dizziness—Prednisone—multiple sclerosis	9.36e-05	0.0018	CcSEcCtD
Tolmetin—Abdominal pain—Methotrexate—multiple sclerosis	9.35e-05	0.0018	CcSEcCtD
Tolmetin—Body temperature increased—Methotrexate—multiple sclerosis	9.35e-05	0.0018	CcSEcCtD
Tolmetin—CXCL8—GPCR downstream signaling—GPR65—multiple sclerosis	9.33e-05	0.000958	CbGpPWpGaD
Tolmetin—CXCL8—AP-1 transcription factor network—IL6—multiple sclerosis	9.26e-05	0.000952	CbGpPWpGaD
Tolmetin—CXCL8—Regulation of toll-like receptor signaling pathway—IL1B—multiple sclerosis	9.14e-05	0.000939	CbGpPWpGaD
Tolmetin—CXCL8—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	9.14e-05	0.000938	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—BDNF—multiple sclerosis	9.11e-05	0.000936	CbGpPWpGaD
Tolmetin—CXCL8—Metabolism of proteins—RPL5—multiple sclerosis	9.11e-05	0.000936	CbGpPWpGaD
Tolmetin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—multiple sclerosis	9.04e-05	0.000928	CbGpPWpGaD
Tolmetin—Vomiting—Prednisone—multiple sclerosis	9e-05	0.00173	CcSEcCtD
Tolmetin—CXCL8—GPCR ligand binding—CNR1—multiple sclerosis	8.98e-05	0.000922	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—RGS1—multiple sclerosis	8.93e-05	0.000918	CbGpPWpGaD
Tolmetin—PTGS1—Selenium Micronutrient Network—ALB—multiple sclerosis	8.93e-05	0.000917	CbGpPWpGaD
Tolmetin—CXCL8—Toll-like Receptor Signaling Pathway—MAPK1—multiple sclerosis	8.92e-05	0.000916	CbGpPWpGaD
Tolmetin—CXCL8—Senescence and Autophagy in Cancer—TGFB1—multiple sclerosis	8.89e-05	0.000913	CbGpPWpGaD
Tolmetin—Headache—Prednisone—multiple sclerosis	8.86e-05	0.0017	CcSEcCtD
Tolmetin—TDO2—Metabolism—BCHE—multiple sclerosis	8.82e-05	0.000906	CbGpPWpGaD
Tolmetin—CXCL8—Senescence-Associated Secretory Phenotype (SASP)—MAPK1—multiple sclerosis	8.72e-05	0.000895	CbGpPWpGaD
Tolmetin—CXCL8—Senescence and Autophagy in Cancer—MAPK1—multiple sclerosis	8.72e-05	0.000895	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—CCR1—multiple sclerosis	8.53e-05	0.000876	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—CXCL13—multiple sclerosis	8.53e-05	0.000876	CbGpPWpGaD
Tolmetin—PTGS2—Selenium Micronutrient Network—ICAM1—multiple sclerosis	8.5e-05	0.000873	CbGpPWpGaD
Tolmetin—CXCL8—Toll-like Receptor Signaling Pathway—TNF—multiple sclerosis	8.49e-05	0.000873	CbGpPWpGaD
Tolmetin—Asthenia—Methotrexate—multiple sclerosis	8.48e-05	0.00163	CcSEcCtD
Tolmetin—CXCL8—Signaling by GPCR—GPR65—multiple sclerosis	8.47e-05	0.00087	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—IL4—multiple sclerosis	8.46e-05	0.000869	CbGpPWpGaD
Tolmetin—Nausea—Prednisone—multiple sclerosis	8.4e-05	0.00162	CcSEcCtD
Tolmetin—CXCL8—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	8.33e-05	0.000856	CbGpPWpGaD
Tolmetin—CXCL8—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	8.23e-05	0.000845	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—LINGO1—multiple sclerosis	8.19e-05	0.000841	CbGpPWpGaD
Tolmetin—CXCL8—Glucocorticoid receptor regulatory network—IL6—multiple sclerosis	8.16e-05	0.000838	CbGpPWpGaD
Tolmetin—PTGS1—Selenium Micronutrient Network—IFNG—multiple sclerosis	8.15e-05	0.000837	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—MYC—multiple sclerosis	8.11e-05	0.000834	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—TGFB1—multiple sclerosis	8.1e-05	0.000832	CbGpPWpGaD
Tolmetin—CXCL8—G alpha (i) signalling events—POMC—multiple sclerosis	8.09e-05	0.000831	CbGpPWpGaD
Tolmetin—Diarrhoea—Methotrexate—multiple sclerosis	8.09e-05	0.00155	CcSEcCtD
Tolmetin—CXCL8—GPCR ligand binding—CXCL10—multiple sclerosis	8.08e-05	0.00083	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—MAPK1—multiple sclerosis	7.94e-05	0.000816	CbGpPWpGaD
Tolmetin—Dizziness—Methotrexate—multiple sclerosis	7.82e-05	0.0015	CcSEcCtD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	7.77e-05	0.000798	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	7.77e-05	0.000798	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—CXCL13—multiple sclerosis	7.75e-05	0.000796	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—CCR1—multiple sclerosis	7.75e-05	0.000796	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	7.72e-05	0.000793	CbGpPWpGaD
Tolmetin—PTGS2—Selenium Micronutrient Network—CCL2—multiple sclerosis	7.61e-05	0.000782	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—TNF—multiple sclerosis	7.56e-05	0.000777	CbGpPWpGaD
Tolmetin—PTGS2—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	7.55e-05	0.000776	CbGpPWpGaD
Tolmetin—Vomiting—Methotrexate—multiple sclerosis	7.52e-05	0.00144	CcSEcCtD
Tolmetin—Headache—Methotrexate—multiple sclerosis	7.41e-05	0.00142	CcSEcCtD
Tolmetin—SLC22A6—Transmembrane transport of small molecules—AQP4—multiple sclerosis	7.41e-05	0.000761	CbGpPWpGaD
Tolmetin—PTGS2—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	7.39e-05	0.000759	CbGpPWpGaD
Tolmetin—PTGS1—Selenium Micronutrient Network—IL1B—multiple sclerosis	7.27e-05	0.000747	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—TAGAP—multiple sclerosis	7.1e-05	0.000729	CbGpPWpGaD
Tolmetin—PTGS2—Selenium Micronutrient Network—ALB—multiple sclerosis	7.09e-05	0.000728	CbGpPWpGaD
Tolmetin—PTGS2—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	7.04e-05	0.000723	CbGpPWpGaD
Tolmetin—Nausea—Methotrexate—multiple sclerosis	7.02e-05	0.00135	CcSEcCtD
Tolmetin—PTGS2—Spinal Cord Injury—TLR4—multiple sclerosis	7.01e-05	0.00072	CbGpPWpGaD
Tolmetin—CXCL8—Regulation of toll-like receptor signaling pathway—MAPK1—multiple sclerosis	6.96e-05	0.000715	CbGpPWpGaD
Tolmetin—CXCL8—GPCR ligand binding—CCL5—multiple sclerosis	6.96e-05	0.000715	CbGpPWpGaD
Tolmetin—CXCL8—Toll-like Receptor Signaling Pathway—IL6—multiple sclerosis	6.85e-05	0.000704	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—ICAM1—multiple sclerosis	6.72e-05	0.000691	CbGpPWpGaD
Tolmetin—CXCL8—Senescence-Associated Secretory Phenotype (SASP)—IL6—multiple sclerosis	6.7e-05	0.000688	CbGpPWpGaD
Tolmetin—CXCL8—Senescence and Autophagy in Cancer—IL6—multiple sclerosis	6.7e-05	0.000688	CbGpPWpGaD
Tolmetin—CXCL8—Metabolism of proteins—BCHE—multiple sclerosis	6.67e-05	0.000685	CbGpPWpGaD
Tolmetin—CXCL8—Regulation of toll-like receptor signaling pathway—TNF—multiple sclerosis	6.63e-05	0.000681	CbGpPWpGaD
Tolmetin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—multiple sclerosis	6.58e-05	0.000676	CbGpPWpGaD
Tolmetin—SLC22A6—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	6.55e-05	0.000672	CbGpPWpGaD
Tolmetin—PTGS2—C-MYB transcription factor network—CD4—multiple sclerosis	6.48e-05	0.000666	CbGpPWpGaD
Tolmetin—PTGS2—Selenium Micronutrient Network—IFNG—multiple sclerosis	6.47e-05	0.000665	CbGpPWpGaD
Tolmetin—CXCL8—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	6.43e-05	0.000661	CbGpPWpGaD
Tolmetin—CXCL8—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	6.29e-05	0.000647	CbGpPWpGaD
Tolmetin—CXCL8—GPCR ligand binding—CCR5—multiple sclerosis	6.27e-05	0.000644	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—S1PR1—multiple sclerosis	6.21e-05	0.000638	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	6.2e-05	0.000637	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—SRM—multiple sclerosis	6.18e-05	0.000635	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—IL6—multiple sclerosis	6.1e-05	0.000627	CbGpPWpGaD
Tolmetin—CXCL8—Cellular Senescence—STAT3—multiple sclerosis	6.07e-05	0.000623	CbGpPWpGaD
Tolmetin—CXCL8—SIDS Susceptibility Pathways—TNF—multiple sclerosis	6.05e-05	0.000621	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—GPC5—multiple sclerosis	6.04e-05	0.00062	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—CCL2—multiple sclerosis	6.02e-05	0.000618	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—PTGER4—multiple sclerosis	5.85e-05	0.000601	CbGpPWpGaD
Tolmetin—PTGS2—Selenium Micronutrient Network—IL1B—multiple sclerosis	5.77e-05	0.000593	CbGpPWpGaD
Tolmetin—PTGS1—Biological oxidations—POMC—multiple sclerosis	5.73e-05	0.000589	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—CXCR3—multiple sclerosis	5.65e-05	0.00058	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—CCL3—multiple sclerosis	5.52e-05	0.000567	CbGpPWpGaD
Tolmetin—CXCL8—Cellular Senescence—MAPK1—multiple sclerosis	5.52e-05	0.000567	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—CCR2—multiple sclerosis	5.5e-05	0.000565	CbGpPWpGaD
Tolmetin—CXCL8—Regulation of toll-like receptor signaling pathway—IL6—multiple sclerosis	5.35e-05	0.00055	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—PTGER4—multiple sclerosis	5.31e-05	0.000546	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—APOE—multiple sclerosis	5.31e-05	0.000545	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	5.31e-05	0.000545	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—RGS1—multiple sclerosis	5.28e-05	0.000542	CbGpPWpGaD
Tolmetin—PTGS1—Selenium Micronutrient Network—TNF—multiple sclerosis	5.27e-05	0.000542	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—CXCR3—multiple sclerosis	5.13e-05	0.000527	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—IFNG—multiple sclerosis	5.12e-05	0.000526	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—CNR1—multiple sclerosis	5.07e-05	0.000521	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—GPR65—multiple sclerosis	5e-05	0.000514	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—CCR2—multiple sclerosis	4.99e-05	0.000513	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—SRM—multiple sclerosis	4.91e-05	0.000504	CbGpPWpGaD
Tolmetin—CXCL8—GPCR ligand binding—POMC—multiple sclerosis	4.9e-05	0.000503	CbGpPWpGaD
Tolmetin—CXCL8—SIDS Susceptibility Pathways—IL6—multiple sclerosis	4.88e-05	0.000501	CbGpPWpGaD
Tolmetin—CXCL8—GPCR ligand binding—CCL2—multiple sclerosis	4.79e-05	0.000492	CbGpPWpGaD
Tolmetin—PTGS2—C-MYB transcription factor network—MYC—multiple sclerosis	4.67e-05	0.000479	CbGpPWpGaD
Tolmetin—SLC22A6—SLC-mediated transmembrane transport—ALB—multiple sclerosis	4.64e-05	0.000476	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—CNR1—multiple sclerosis	4.61e-05	0.000473	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—STAT3—multiple sclerosis	4.59e-05	0.000471	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CXCL13—multiple sclerosis	4.58e-05	0.00047	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CCR1—multiple sclerosis	4.58e-05	0.00047	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—CXCL10—multiple sclerosis	4.57e-05	0.000469	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—IL1B—multiple sclerosis	4.56e-05	0.000469	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—POMC—multiple sclerosis	4.56e-05	0.000468	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—IL2—multiple sclerosis	4.55e-05	0.000467	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—CYP27B1—multiple sclerosis	4.36e-05	0.000448	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—CYP24A1—multiple sclerosis	4.36e-05	0.000448	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—MMP9—multiple sclerosis	4.3e-05	0.000442	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	4.26e-05	0.000437	CbGpPWpGaD
Tolmetin—PTGS1—Selenium Micronutrient Network—IL6—multiple sclerosis	4.26e-05	0.000437	CbGpPWpGaD
Tolmetin—CXCL8—Cellular Senescence—IL6—multiple sclerosis	4.24e-05	0.000435	CbGpPWpGaD
Tolmetin—PTGS2—Selenium Micronutrient Network—TNF—multiple sclerosis	4.19e-05	0.00043	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—MAPK1—multiple sclerosis	4.17e-05	0.000428	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—ALB—multiple sclerosis	4.16e-05	0.000427	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—CXCL10—multiple sclerosis	4.15e-05	0.000426	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—GPC5—multiple sclerosis	3.98e-05	0.000409	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—CCL5—multiple sclerosis	3.93e-05	0.000404	CbGpPWpGaD
Tolmetin—PTGS2—Disease—GPC5—multiple sclerosis	3.78e-05	0.000388	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—CCL5—multiple sclerosis	3.57e-05	0.000367	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—MYC—multiple sclerosis	3.55e-05	0.000365	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—TGFB1—multiple sclerosis	3.55e-05	0.000364	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—CCR5—multiple sclerosis	3.54e-05	0.000364	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—IL2RA—multiple sclerosis	3.49e-05	0.000359	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—MAPK1—multiple sclerosis	3.48e-05	0.000357	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—CYP24A1—multiple sclerosis	3.46e-05	0.000355	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—CYP27B1—multiple sclerosis	3.46e-05	0.000355	CbGpPWpGaD
Tolmetin—CXCL8—Metabolism of proteins—POMC—multiple sclerosis	3.45e-05	0.000354	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.38e-05	0.000347	CbGpPWpGaD
Tolmetin—PTGS2—Selenium Micronutrient Network—IL6—multiple sclerosis	3.38e-05	0.000347	CbGpPWpGaD
Tolmetin—CXCL8—Metabolism of proteins—CCL2—multiple sclerosis	3.37e-05	0.000346	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—TNF—multiple sclerosis	3.31e-05	0.00034	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—RRM1—multiple sclerosis	3.3e-05	0.000339	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CCL3—multiple sclerosis	3.26e-05	0.000335	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—CCR5—multiple sclerosis	3.22e-05	0.00033	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—IL6—multiple sclerosis	3.2e-05	0.000329	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—IL2RA—multiple sclerosis	3.17e-05	0.000326	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—GPC5—multiple sclerosis	3.16e-05	0.000325	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—PTGER4—multiple sclerosis	3.14e-05	0.000322	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—PGR—multiple sclerosis	3.09e-05	0.000318	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CXCR3—multiple sclerosis	3.03e-05	0.000311	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CD28—multiple sclerosis	3e-05	0.000308	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CCR2—multiple sclerosis	2.95e-05	0.000303	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—POMC—multiple sclerosis	2.77e-05	0.000284	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CNR1—multiple sclerosis	2.72e-05	0.00028	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—IL6—multiple sclerosis	2.67e-05	0.000274	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—RRM1—multiple sclerosis	2.62e-05	0.000269	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.56e-05	0.000263	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—POMC—multiple sclerosis	2.51e-05	0.000258	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—CCL2—multiple sclerosis	2.46e-05	0.000253	CbGpPWpGaD
Tolmetin—PTGS2—Disease—RPL5—multiple sclerosis	2.46e-05	0.000252	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CXCL10—multiple sclerosis	2.45e-05	0.000252	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	2.42e-05	0.000248	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	2.41e-05	0.000248	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	2.37e-05	0.000243	CbGpPWpGaD
Tolmetin—SLC22A6—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.36e-05	0.000242	CbGpPWpGaD
Tolmetin—PTGS2—Disease—SLC11A1—multiple sclerosis	2.35e-05	0.000242	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	2.25e-05	0.000231	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—TYK2—multiple sclerosis	2.23e-05	0.000229	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.2e-05	0.000226	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CD86—multiple sclerosis	2.14e-05	0.00022	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CCL5—multiple sclerosis	2.11e-05	0.000217	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—IL2—multiple sclerosis	2.05e-05	0.00021	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.03e-05	0.000209	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.01e-05	0.000206	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—SPP1—multiple sclerosis	1.95e-05	0.000201	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CCR5—multiple sclerosis	1.9e-05	0.000195	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—BCHE—multiple sclerosis	1.9e-05	0.000195	CbGpPWpGaD
Tolmetin—PTGS2—Disease—CD28—multiple sclerosis	1.88e-05	0.000193	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—IL2RA—multiple sclerosis	1.87e-05	0.000192	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—IL2—multiple sclerosis	1.86e-05	0.000191	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.75e-05	0.000179	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—APOE—multiple sclerosis	1.73e-05	0.000178	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.59e-05	0.000164	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CD80—multiple sclerosis	1.56e-05	0.000161	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—BCHE—multiple sclerosis	1.51e-05	0.000155	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—POMC—multiple sclerosis	1.48e-05	0.000153	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CCL2—multiple sclerosis	1.45e-05	0.000149	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—MAPK1—multiple sclerosis	1.42e-05	0.000146	CbGpPWpGaD
Tolmetin—PTGS2—Disease—CD86—multiple sclerosis	1.34e-05	0.000138	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—TYK2—multiple sclerosis	1.32e-05	0.000136	CbGpPWpGaD
Tolmetin—PTGS2—Disease—CCR5—multiple sclerosis	1.19e-05	0.000122	CbGpPWpGaD
Tolmetin—PTGS2—Disease—HLA-A—multiple sclerosis	1.16e-05	0.000119	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—APOE—multiple sclerosis	1.14e-05	0.000117	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—IL2—multiple sclerosis	1.1e-05	0.000113	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—IL6—multiple sclerosis	1.09e-05	0.000112	CbGpPWpGaD
Tolmetin—PTGS2—Disease—APOE—multiple sclerosis	1.08e-05	0.000111	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—MMP9—multiple sclerosis	1.04e-05	0.000107	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—POMC—multiple sclerosis	9.8e-06	0.000101	CbGpPWpGaD
Tolmetin—PTGS2—Disease—CD80—multiple sclerosis	9.78e-06	0.0001	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—STAT3—multiple sclerosis	9.24e-06	9.49e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—APOE—multiple sclerosis	9.06e-06	9.3e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—ALB—multiple sclerosis	8.93e-06	9.18e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—MYC—multiple sclerosis	8.58e-06	8.82e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—TGFB1—multiple sclerosis	8.56e-06	8.8e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—MAPK1—multiple sclerosis	8.4e-06	8.63e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—TYK2—multiple sclerosis	8.25e-06	8.48e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—POMC—multiple sclerosis	7.78e-06	7.99e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—CD4—multiple sclerosis	7.46e-06	7.67e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—ALB—multiple sclerosis	7.09e-06	7.29e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—IL6—multiple sclerosis	6.45e-06	6.63e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—STAT3—multiple sclerosis	5.78e-06	5.94e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—MYC—multiple sclerosis	5.37e-06	5.52e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—TGFB1—multiple sclerosis	5.36e-06	5.5e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—MAPK1—multiple sclerosis	5.25e-06	5.4e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—IL6—multiple sclerosis	4.04e-06	4.15e-05	CbGpPWpGaD
